ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Advanced Search

Predicting the Ability of Anti-HLA Antibodies to Activate Complement.

D. Bekbolsynov, C. Baum, B. Mierzejewska, A. Malebari, M. Rees, S. Stepkowski.

University of Toledo, Toledo.

Meeting: 2016 American Transplant Congress

Abstract number: D2

Keywords: HLA antibodies, Kidney transplantation, Screening, Waiting lists

Session Information

Date: Tuesday, June 14, 2016

Session Name: Poster Session D: Antibody Mediated Rejection: Session #2

Session Time: 6:00pm-7:00pm

 Presentation Time: 6:00pm-7:00pm

Location: Halls C&D

Related Abstracts
  • Relationship Between Mean Fluorescence Intensity and C1q/C3d-Fixing Capacities of Anti-HLA Antibodies.
  • Utility of Anti-Phospholipase A2 Receptor (Anti-PLA2R) ELISA Testing in Predicting Post-Transplant Idiopathic Membranous Nephropathy (IMN)

Purpose: The single antigen bead (SAB) assay measures binding of antibodies (Abs) to HLA in units of mean florescence intensity (MFI). Two assays measure the potential of Abs for complement activation by testing C1q or C3d deposition. We examined whether SAB MFI correlates with C1q or C3d positivity.

Methods: Sera of 17 patients (PRA>80%) were analyzed for anti-HLA-I Abs in SAB, C1q, and C3d assays using sera neat or diluted 1:4 or 1:64; an MFI of 1000 was considered positive in C1q and positivity in C3d was determined by MatchIT. For the predictive performance of SAB, receiver-operating characteristics (ROC) and logistic regression modeling were done; statistical significance was assessed by Wald's test.

Results: The sensitivity and specificity of SAB for prediction of C1q positivity were both equal to 0.91 at 6,500 MFI. Thus, 91% of the time, a bead is C1q positive if it has an SAB MFI of 6,500 or higher. An SAB MFI cutoff of 6,500 yields an area under the curve (AUC) of 0.95 in ROC analysis. The optimal MFI cutoff was also at 6,500 for C3d positivity, yielding sensitivity and specificity of 0.88 and an AUC of 0.91 (Fig. 1). Logistic regression predicts dichotomous outcomes for C1q and C3d based on SAB MFI. In particular, the probability of SAB+ Abs for beads with MFI over 20,000 to be C1q or C3d positive was 99.3% and 79.9%, respectively. In contrast, at MFI of 1,000 the probability dropped to 1.0% for C1q and 1.7% for C3d (Fig. 2). Wald's test confirmed significant reliability.

Conclusion: Statistical analyses of titrated sera for highly sensitized patients indicate that SAB MFI results correlate with C1q and C3d results. These analyses indicate good diagnostic accuracy for C1q and C3d assays. Finally, SAB MFI predicts the cytotoxic potential of HLA-specific Abs.

CITATION INFORMATION: Bekbolsynov D, Baum C, Mierzejewska B, Malebari A, Rees M, Stepkowski S. Predicting the Ability of Anti-HLA Antibodies to Activate Complement. Am J Transplant. 2016;16 (suppl 3).

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Bekbolsynov D, Baum C, Mierzejewska B, Malebari A, Rees M, Stepkowski S. Predicting the Ability of Anti-HLA Antibodies to Activate Complement. [abstract]. Am J Transplant. 2016; 16 (suppl 3). https://atcmeetingabstracts.com/abstract/predicting-the-ability-of-anti-hla-antibodies-to-activate-complement/. Accessed April 20, 2021.

« Back to 2016 American Transplant Congress

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Kidney Dialysis after Heart Transplantation: The Short and Long Term Outcomes
  • Penis Transplantation: First U.S. Experience.
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Penis Transplantation: First U.S. Experience.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Live Related Kidney Transplant Experience in Abuja, Nigeria – First Eight Cases Ever.
  • Penis Transplantation: First U.S. Experience.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Evidence of a Clinically Significant Drug-Drug Interaction between Cannabidiol and Tacrolimus: A Case Report
  • Kidney Dialysis after Heart Transplantation: The Short and Long Term Outcomes

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2021 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.